While hormonal causes are less common than genetics or weight, theyre important to consider especially if under-chin fullness appears suddenly, fluctuates, or is accompanied by other systemic symptoms such as fatigue or swelling elsewhere
Just recently approved by Health Canada in January 2026, Rybelsus is the first and only once-daily GLP-1 tablet option for managing diabetes in Canada. Provincial Insurance Coverage: Who Gets Help Paying
Many patients on long-term prednisone are on more than they need
For semaglutide specifically, studies found the average duration was about 47 days
To summarize, on one hand the modest upwards trajectory of the obese and diabetic population provides a fertile ground for Pharma companies to sell more for the years to come, however, downside risks remain, including: pricing, compounders and overall competition, which will make it hard for companies like Novo and Lilly to maintain their growth
These medications work by mimicking the action of naturally occurring GLP-1 , a hormone released by the intestine in response to food intake